Načítá se...
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy
Introduction: The second-generation 5-hydroxytryptamine-3 (5-HT(3)) receptor antagonist palonosetron is effective in the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with highly and moderately emetogenic chemotherapy (HEC and MEC, respectively). In addition, palonosetron...
Uloženo v:
| Vydáno v: | Core Evid |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554402/ https://ncbi.nlm.nih.gov/pubmed/26345982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S65555 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|